BG Medicine Announces Peer-Reviewed Publication of The BioImage Study

WALTHAM, Mass.--(BUSINESS WIRE)--BG Medicine, Inc., a U.S.-based biomarker discovery and in vitro diagnostics company, announced today the publication of The BioImage Study trial design and key objectives in the American Heart Journal. The American Heart Journal is a peer- reviewed journal that publishes original research and review articles on clinical research studies in the field of cardiology. The article which appeared in the July issue is titled “The BioImage Study: Novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease—study design and objectives,” Pieter Muntendam, MD, Carol McCall, FSA, MAAA, Javier Sanz, MD, Erling Falk, MD, PhD, Valentin Fuster, MD, PhD, on behalf of the High-Risk Plaque Initiative. Volume 160, Issue 1, Pages 49-57, e1, (July 2010), http://www.ahjonline.com/article/S0002-8703%2810%2900165-1/abstract